natgillin/translations-raw huggingface dataset:
(84,2 mil-(2003 figures) 28.12.2005 EN Official Journal of the European Union C 332/11 Origin of revenue Revenue entered in the final budget for the financial year Revenue collected Allocation of expenditure outstand- Community subsidies (1) 29 073 29 022 Title I Staff 36 064 34 151 33 509 642 1 913 534 424 110 36 598 34 685 33 933 642 2 023 Own revenue 67 000 67 350 Title II Administration 23 994 23 878 12 943 10 935 116 7 265 6 749 516 31 259 31 143 19 692 10 935 632 Other revenue 3 016 3 013 Title III Operating activities 39 031 38 686 27 512 11 174 345 8 316 7 878 438 47 347 47 002 35 390 11 174 783 Total 99089 99385 Total 99089 96715 73964 22751 2374 16115 15051 1064 115204 112830 89015 22751 3438 Revenue Expenditure (1) Including subsidies received from the European Economic Area. 
28.12.2005 ET Euroopa Liidu Teataja C 332/11 Tulude pritolu Eelarveaasta lplikusse eelarvesse kantud tulud Laekunud tulud Kulude jaotamine titma-henduse toetused (1) 29 073 29 022 Jaotis I Personal stused 36064 34151 33509 642 1913 534 424 110 36598 34685 33933 642 2023 Omatulud Muud tulud 67 000 67 350 Jaotis II Haldustegevus 23994 23878 12943 10935 116 7265 6749 516 31259 31143 19692 10935 632 39031 38686 27512 11174 345 8316 7878 438 47347 47002 35390 11174 783 Kokku 99 089 99 385 Kokku 99089 96715 73964 22751 2374 16115 15051 1064 115204 112830 89015 22751 3438 Tulud Kulud 3 016 3 013 Jaotis III Phitegevus (1) Sealhulgas Euroopa Majanduspiirkonnalt saadud toetused.
Source: The AgencyŐs data Ń This table summarises the data provided by the Agency in its annual accounts. Table 2 European Medicines Agency Ń Implementation of the budget for the financial year 2004 Appropriations in the final budget Appropriations carried over from the previous financial year Appropriations available (2004 budget and financial year 2003) entered com-paid carried can-ing paid can-appro- commit-paid carried cancelled mitted over celled commit- ments celled priations ted over (1 000 euro) 
Allikas: Ameti andmed Ń tabelis tehakse kokkuvte ameti poolt aastaaruannetes esitatud andmetest. kirjen-maks- lekan-thista- ta maks-thista- assignee-maks- lekan-thista- Tabel 2 Euroopa Ravimiamet Ń eelarve titmine 2004. eelarveaastal Assigneeringud lplikus eelarves Eelmisest eelarveaastast le kantud assigneeringud Olemasolevad assigneeringud (2004. aasta eelarve ja 2003. eelarveaasta) datud vetud tud tud tud kulu-tud tud ringud vetud tud tud tud kohu-(1 000 eurot)
C 332/12 EN Official Journal of the European Union Table 3 28.12.2005 (1 000 euro) 2003 (1) 58 657 19 786 2 814 1 208 1 703 1 788 85 956 29 663 10 835 32 838 2 364 0 75 700 10 256 676 10 932 European Medicines Agency Ń Revenue and expenditure account for the financial years 2004 and 2003 Revenue Fees relating to marketing authorisations Commission subsidy including contributions received from the EEA Community subsidy for orphan medicines Contributions for Community programmes Administrative revenue Sundry revenue Expenditure Staff expenditure Administrative expenditure Operating expenditure Depreciation Other expenses Total (a) Total (b) Operating result (c = a Đ b) Financial result (e) Economic outturn (f = c + e) 2004 68 412 20 529 4 026 0 1 973 1 473 96 413 34 333 11 224 38 573 3 650 280 88 060 8 353 1 160 9 513 (1) The data for the financial year 2003 have been reprocessed to make them comparable to those of 2004. 
C 332/12 ET Euroopa Liidu Teataja 28.12.2005 Tabel 3 Euroopa Ravimiamet Ń 2004. ja 2003. eelarveaasta tulude ja kulude aruanne Tulud 2004 68 412 20 529 4 026 0 1 973 1 473 96 413 34 333 11 224 38 573 3 650 280 88 060 8 353 1 160 9 513 (1 000 eurot) 2003 (1) 58 657 19 786 2 814 1 208 1 703 1 788 85 956 29 663 10 835 32 838 2 364 0 75 700 10 256 676 10 932 Mgilubadega seotud tasud Komisjoni toetus, sealhulgas EMPlt saadud toetused henduse toetus orbude ravimite jaoks Panus henduse programmidesse Haldustulud Mitmesugused tulud Kulud Personalikulud Halduskulud Tegevuskulud Amortisatsioon Muud kulud Kokku (a) Kokku (b) Tegevustulemus (c = a Đ b) Finantstulemus (e) Majandustulemus (f = c + e) (1) 2003. eelarveaasta andmed on mber arvestatud, et muuta need vrreldavateks 2004. eelarveaasta andmetega.
Source: The AgencyŐs data Ń This table summarises the data provided by the Agency in its annual accounts. 
Allikas: Ameti andmed Ń tabelis tehakse kokkuvte ameti poolt aastaaruannetes esitatud andmetest.
28.12.2005 EN Official Journal of the European Union C 332/13 Assets 2004 5 109 2 480 1 375 3 151 7 006 1 888 148 1 795 2 061 5 892 35 010 53 017 2003 3 401 1 635 1 011 2 548 5 194 1 105 107 1 034 64 2 310 28 286 39 191 Liabilities (1 000 euro) 2004 2003 Amounts owed by Community institutions and bodies Current liabilities Other accounts payable Advances from customers Sundry accounts receivable Sundry receivables and advances Available assets Subtotal Total Subtotal Total Table 4 European Medicines Agency Ń Balance sheet at 31 December 2004 and 31 December 2003 Intangible assets Fixed assets Own capital Plant, machinery and tools Furniture and vehicle fleet Computer equipment Current assets VAT paid and to be recovered Economic outturn Current liabilities Subtotal Subtotal Amounts owed in social security charges Amounts owed to Community institutions and bodies Outturn carried over from previous financial years 13 767 9 513 23 280 320 4 910 13 151 106 11 250 29 737 53 017 6 872 10 932 17 804 0 479 11 936 127 8 845 21 387 39 191 Source: The AgencyŐs data Ń This table summarises the data provided by the Agency in its annual accounts. 
28.12.2005 ET Euroopa Liidu Teataja C 332/13 Varad Seadmestik, masinad ja triistad Sisustus ja sidukid Arvutiseadmed Kibevara Makstud ja sissenutav kibemaks 2004 5 109 2 480 1 375 3 151 7 006 1 888 148 1 795 2 061 5 892 35 010 53 017 2003 3 401 1 635 1 011 2 548 5 194 1 105 107 1 034 64 2 310 28 286 39 191 Kohustused (1 000 eurot) 2004 2003 henduse institutsioonidelt ja asutustelt saadaolevad summad Mitmesugused laekumata arved Mitmesugused saadaolevad summad ja ettemaksed Jooksvad kohustused Muud vlgnevused Klientide ettemaksed Tabel 4 Euroopa Ravimiamet Ń bilanss 2004. aasta 31. detsembri ja 2003. aasta 31. detsembri seisuga Immateriaalne vara Phivara Omakapital Eelmistest eelarveaastatest le kantud tulemused 13 767 9 513 23 280 320 4 910 13 151 106 11 250 29 737 53 017 6 872 10 932 17 804 0 479 11 936 127 8 845 21 387 39 191 Majandustulemused Lhiajalised kohustused Vahesumma Olemasolevad varad Vahesumma Kokku Vahesumma Kokku Vahesumma Sotsiaalkindlustusmaksete vlgnevused Vlgnevused henduse institutsioonidele ja asutustele Allikas: Ameti andmed Ń tabelis tehakse kokkuvte ameti poolt aastaaruannetes esitatud andmetest.
C 332/14 EN Official Journal of the European Union 28.12.2005 THE AGENCYŐS REPLIES 7. 
C 332/14 ET Euroopa Liidu Teataja 28.12.2005 AMETI VASTUSED 7.
On 4 February 2005 the Management Board of the agency adopted the Terms of Reference of the Audit Advisory Committee which include the mission statement of this committee as well as the rules of proceedings. 
2005. aasta 4. veebruaril vttis ameti haldusnukogu vastu kontrollikomisjoni tkorra, mis sisaldab komisjoni eesmrki ja menetluste eeskirju.
The Agency has had to implement a wide-ranging reform of the Financial Regulation and Accounting procedures over the last few years. 
Viimastel aastatel on ametil tulnud rakendada laiaulatuslikku finantsmruse ja raamatupidamisprotseduuride reformi.
It was considered prudent not to seek a change in the main bank at the same time due to the integration of our systems with this bankŐs electronic payment system. 
Peeti mistlikuks samal ajal mitte muuta philist panka, sest meie ssteemid on integreeritud selle panga elektroonilise maksess-teemiga.
However it should be noted that substantial reductions in bank transfer costs have been achieved through direct negotiations with the bank and automation of payments. 
Tuleb siiski mrkida, et tnu otsestele lbi-rkimistele pangaga ja automatiseeritud maksetele on suudetud oluliselt vhendada pangalekannete kulusid.
Also placements of funds are subject to individual bids from up to three banks based on the market rates on a particular day. 
Samuti tehakse ka-pitalipaigutusi vastava peva turukursi alusel, saades kuni kolmelt pangalt ksikpakkumisi.
The Agency notes with satisfaction that these points, mentioned in the CourtŐs report on the 2003 accounts, have been resolved. 
Amet mrgib rahuldustundega, et kontrollikoja aruandes mrgitud punktid 2003. aasta raamatupidamisarvestuse kohta on leidnud lahenduse.
Paragraph Page 28 28 28 30 33 1-2 3-6 
Punktid Lk 28 28 28 30 33
C 311/28 EN Official Journal of the European Union 5.12.2008 INTRODUCTION 1. 
C 311/28 ET Euroopa Liidu Teataja 5.12.2008 SISSEJUHATUS 1.
The European Medicines Agency (hereinafter the Agency) was created by Council Regulation (EEC) No 2309/93 of 22 July 1993, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 (1). 
Euroopa Ravimiamet (edaspidi amet) asutati nukogu 22. juuli 1993. aasta mrusega (EM) nr 2309/93, mis asendati Euroopa Parlamendi ja nukogu 31. mrtsi 2004. aasta mrusega (E) nr 726/2004 (1).
The Agency operates through a network and coordinates the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use. 
Amet toimib vrgustiku kaudu ja koordineerib siseriiklike ametiasutuste poolt kttesaadavaks tehtud teadusressursse, et tagada inim-vi veterinaarravimite hindamine ja jrelevalve.
Key data summarised from the financial statements drawn up by the Agency for the financial year 2007 are presented inTables 2, 3 and 4for information purposes. 
Ameti poolt koostatud 2007. eelarveaasta raamatupidamisaruande phiteave on teavitamise eesmrgil toodud tabelites 2, 3 ja 4.
This Statement is addressed to the European Parliament and the Council in accordance with Article 185(2) of Council Regulation (EC, Euratom) No 1605/2002 (2); it was drawn up following an examination of the AgencyŐs accounts, as required by Article 248 of the Treaty establishing the European Community. 
Kesolev kinnitav avaldus on adresseeritud Euroopa Parlamendile ja nukogule koosklas nukogu mruse (E, Euratom) nr 1605/2002 artikli 185 likega 2: (2) avaldus koostati prast ameti raamatupidamisaruande kontrollimist vastavalt Euroopa henduse asutamislepingu artiklile 248.
The AgencyŐs accounts for the financial year ended 31 December 2007 (3) were drawn up by its Executive Director, pursuant to Article 68 of Regulation (EC) No 726/2004, and sent to the Court, which is required to give a Statement of Assurance on their reliability and on the legality and regularity of the underlying transactions. 
Vastavalt mruse (E) nr 726/2004 artiklile 68 koostas ameti tegevdirektor 31. detsembril 2007 (3) lppenud eelarveaasta raamatupidamisaruande ja see saadeti kontrollikojale, mille lesandeks on anda arvamus raamatupidamisaruannete usaldusvrsuse ja nende aluseks olevate tehingute seaduslikkuse ja korrektsuse kohta.
The Court conducted its audit in accordance with the IFAC and ISSAI (4) International Auditing Standards and Codes of Ethics, insofar as these are applicable in the European Community context. 
Kontrollikoda viis auditi lbi koosklas IFAC ja ISSAI (4) rahvusvaheliste auditistandardite ja eetikanormidega sel mral, kuivrd neid on vimalik henduse kontekstis rakendada.
(1) OJ L 214, 24.8.1993, p. 18 and OJ L 136, 30.4.2004, p. 1. 
(1) ET L 214, 24.8.1993, lk 18 ja ELT L 136, 30.4.2004, lk 1.
Pursuant to the latter Regulation the AgencyŐs original name, the European Agency for the Evaluation of Medicinal Products, was changed to the European Medicines Agency. 
Vastavalt viimati mainitud mrusele muudeti ameti esialgne nimi, Euroopa Ravimihindamisamet, Euroopa Ravimiametiks.
(3) These accounts were drawn up on 15 June 2008 and received by the Court on 1 July 2008. 
(3) Raamatupidamisaruanne koostati 15. juunil 2008 ning kontrollikoda sai selle 1. juulil 2008.
The AgencyŐs final budget for 2007 amounted to 163,1 million euro as compared with 138,7 million euro the previous year. 
Ameti 2007. aasta lplik eelarve oli 163,1 miljonit eurot; eelmise aasta eelarve oli 138,7 miljonit eurot.
Of the budget appropriations, 32 million euro were carried over and 4 million euro were cancelled. 
Eelarveassigneerin-gutest 32 miljonit eurot kanti le ja 4 miljonit eurot annulleeriti.
As in 2006, the high level of carry-overs for administrative expenditure, 18,9 million euro, was mainly due to the programme Telematics for the regulation of medical products. 
Sarnaselt 2006. aastaga oli halduskuludeks eraldatud assigneeringute lekannete krge tase Đ 18,9 miljonit eurot Đ seotud ravimite valdkonna reguleerimisele suunatud telemaatikaprogrammiga.
The Agency and the other parties involved in this programme must ensure better planning and monitoring of the implementation of the programme. 
Ametil ja teistel programmiga seotud osapooltel tuleb tagada programmi elluviimise parem planeerimine ja jrelevalve.
The Agency should consider using the differentiated appropriations system for the Telematics programme which is more suitable for the budgetary management of such programmes. 
Amet peaks kaaluma telemaatikaprogrammi osas liigendatud assigneeringute ssteemi kasutamist, mis on seda liiki programmide eelarve haldamiseks kohasem.
The audit of the tendering procedures showed weaknesses: insufficient justification of the chosen procedures (5) and inadequate evaluation methods for the price criteria (6). 
Hankemenetluste auditeerimisel leiti jrgmisi puudusi: valitud menetluste ebapiisav phjendatus (5) ja hinnakriteeriumide ebasobivad hindamismeetodid (6). he riigihankemenetluse puhul, mis viidi lbi hiselt koos viie teise asutusega, ei olnud sisseostetavate teenuste maht nuetekohaselt kindlaksmratud.
This resulted in difficulties in evaluating the cost of the bids as well as the need to review the volumes and values of the services to be procured. 
See phjustas raskusi pakkumiste maksumuse hindamises ning tingis vajaduse sisseostetavate teenuste maht ja vrtus uuesti le vaadata.
The Agency should aim to improve the quality of its public procurement procedures in order to address the issues highlighted above. 
Amet peaks pdma parandada oma riigihankemenetluste kvaliteeti, et laltoodud probleemid lahendada.
(5) Two cases. 
(5) Kaks juhtumit.
(6) Three cases. 
(6) Kolm juhtumit.
5.12.2008 EN Official Journal of the European Union C 311/29 9. 
5.12.2008 ET Euroopa Liidu Teataja C 311/29 9.
In its 2006 report (1), the Court observed that the Agency had not performed a comprehensive analysis of the costs incurred by rapporteurs. 
Kontrollikoda mrkis 2006. aasta aruandes, (1) et amet ei olnud phjalikult analsinud liikmesriikide ettekandjate kulusid.
The Management Board of the Agency has established a Costing Group which at the end of 2007 prepared a report on a generally accepted international costing methods and a proposal for an alternative option for remunerating the rapporteurs. 
Ameti haldusnukogu on moodustanud kuluarvestuse trhma, mis 2007. aasta lpus koostas aruande ldiselt heakskiidetud rahvusvahelistest kuluarvestuse meetoditest ja esitas ettekandjate tasustamise alternatiivse mooduse ettepaneku.
The Court welcomes the steps the Agency has made in order to address the issue of the evaluation of the costs and calls for further progress. 
Kontrollikoda tervitab ameti poolt kuluhindamise probleemi lahendamiseks vetud meetmeid ja kutsub les edusamme jtkama.
For the Court of Auditors Vtor Manuel da SILVA CALDEIRA President (1) OJ C 309, 19.12.2007, p. 34. 
Kontrollikoja nimel president Vtor Manuel da SILVA CALDEIRA (1) ELT C 309, 19.12.2007, lk 34.
C 311/30 EN Official Journal of the European Union 5.12.2008 Areas of Community competence deriving from the Treaty Competences of the Agency as defined in Regulation (EC) No 726/2004 of the European Parliament and of the Council Governance 1. The Committee for Medicinal Products for Resources made available to the Agency in 2007 (Data for 2006) Products and Services in 2007 A high level of human health protection shall be ensured in the definition and implementation of all Community policies and activities. 
C 311/30 ET Euroopa Liidu Teataja 5.12.2008 Asutamislepingust tulenev henduse pdevusvaldkond Euroopa Parlamendi ja nukogu mruses (E) nr 726/2004 mratud ameti pdevus Juhtimine 2007. aastal ameti ksutusse antud ressursid (2006. aasta andmed) 2007. aasta tooted ja teenused Kogu henduse poliitika ja meetmete mratlemisel ja rakendamisel tagatakse inimeste tervise krgetasemeline kaitse.
Objectives Tasks Final budget for 2007: Medicinal Products for Human Use Community action, which shall complement national policies, shall be directed towards improving public health, preventing human illness and diseases and obviating sources of danger to human health. (...) of medicinal products for human and veterinary use. 
Eesmrgid lesanded 1 mis koosneb iga liikmesriigi poolt nimetatud liikmest ja asendusliikmest, annab nu kikides inimravimite hindamist puudutavates ksimustes. henduse meetmed, mis tiendavad riikide poliitikat, on suunatud rahvatervise parandamisele, inimeste haiguste ennetamisele ja inimeste tervist ohustavate tegurite krvaldamisele. (...)
Ń 2. The Committee for Medicinal Products for Veterinary Use, consisting of one member and one alternate from each MemberState, advises on any question relating to the evaluation of veterinary medicinal products. 
2 Veterinaarravimikomitee, mis koosneb iga liikmesriigi poolt nimetatud liikmest ja asendusliikmest, annab nu kikides veterinaarravimite hindamist puudutavates ksimustes.
Community contribution (excluding subsidy for orphan medicines): 24,3 % (21,6 %) Ń Favourable opinions: 58 (51); Ń Average evaluation time: (Article 152 of the Treaty) Posts occupied: 422 (395) 95 (77) other staff (auxiliary agents, 150 188 reports (94 081 reports); Source: Information supplied by the Agency. 
Ń Positiivseid arvamusi: 58 (51) (Asutamislepingu artikkel 152) Anda soovitusi veterinaarravimijkide lubatavate piirmrade kohta loomsetes toiduainetes. 441 (424) tkohta ametikohtade loetelus Ń Ravimiohutuse jrelevalve: 150 188 aruannet (94 081 aruannet) Allikas: ameti edastatud teave.
Ń To coordinate the scientific Ń resources that the Member StatesŐ authorities make available to the Agency for the authorisation and supervision To coordinate the scientific evaluation of medicinal products which are subject to Community marketing authorisation procedures. 
Ń Koordineerida liikmesriikide Ń ametivimude poolt ameti ksutusse antud teadusressursse, et anda lube inim-ja veterinaarravimite kohta ja teostada ravimite le jrelevalvet.
Human Use, consisting of one member and one alternate from each MemberState, advises on any question relating to the evaluation of medicinal products for human use. 
Ń Koordineerida henduse mgilubade korrale alluvate ravimite teaduslikku hindamist. eurot) henduse toetus (v.a toetus harva Ń Mgiloa taotlusi: 91 (79) Ń Anda liikmesriikidele ja Euroopa Liidu asutustele teaduslikku nu inim-vi veteri-Ń naarravimite kohta.
The Committee on Herbal Medicinal Products, consisting of one member and one alternate from each MemberState, advises on any question relating to the evaluation of herbal medicinal products. contract agents seconded national experts, employment agency staff) Ń Periodic safety update reports: 313 (273); Ń To coordinate verification of compliance with the principles of good manufacturing practice, good laboratory practice and good clinical practice. 
4 Taimravimikomitee, mis koosneb iga liikmesriigi poolt nimetatud liikmest ja asendusliikmest, annab nu kikides taimsete ravimite hindamist puudutavates ksimustes.
The Board adopts the work programme and the annual report. 
Nukogu vtab vastu tprogrammi ja aasta ldaruande. phitlesanded: 444 (406) Veterinaarravimid 7 Tegevdirektori nimetab ametisse haldusnukogu komisjoni ettepanekul.
The Executive Director is appointed by the Management Board on a proposal from the Commission. 
9 Eelarve titmist kinnitav asutus Parlament nukogu soovitusel.
9. Discharge authority Parliament acting on recommendation of the Council. Ń Requests for SME status 212 (145); Total staff: 518 (472) Assigned to the following duties: Operational: 444 (406) Administrative: 74 (66) Ń Scientific opinions: 215 (193); Ń Procedures for mutual recogni-(Data for 2006) investigation plans: 85 (0) relating to 202 (0) indications. 
Ń Positiivseid arvamusi: 97 (81) 2007. aasta lplik eelarve: mis jaguneb vastavalt jrgmistele lesannetele: Ń Pediaatrilise uuringu programmi taotlusi: 85 (0) taotlust 202 (0) nidustuse osas halduslesanded: 74 (66) Ń Uusi taotlusi: 14 (5) Ń Taotlusi variantide osas: (2006. aasta andmed) 100 (56) Ń Kontrolle: 185 (128) Harva kasutatavad ravimid Vikesed ja keskmise suurusega ettevtjad (VKE) Ń Taotlusi VKE staatuse saamiseks 212 (145) Ń Tasu vhendamise vi edasilkkamise taotlusi: 81
5.12.2008 EN Official Journal of the European Union C 311/31 Source of revenue Revenue entered in the final budget for the financial year Revenue collected Allocation of expenditure Appropriations carried over from previous year(s) Own revenue Community subsidies 113 659 40 548 116 799 40 548 Title I Staff 764 Other subsidies Other revenue 6 706 2 200 5 475 2 467 Title II Administration 47 198 64 783 44 758 64 497 25 863 52 118 18 895 12 379 2 440 286 15 061 13 585 14 360 13 257 701 328 Total 163 113 165 289 Total 163 113 159 126 127 088 32 038 3 987 29 413 28 278 1 135 Revenue Expenditure Final budget appropriations Title III Operating activities NB: Any discrepancies in totals are due to the effects of rounding. 
5.12.2008 ET Euroopa Liidu Teataja C 311/31 Tuluallikas Kogutud tulud Kulude jaotus kulukohustustega seotud annulleeritud annulleeritud Omatulud henduse toetused 113 659 40 548 116 799 40 548 I jaotis Personal 51 132 49 871 49 107 764 1 261 767 661 106 Muud toetused Muud tulud 6 706 2 200 5 475 2 467 II jaotis Haldustegevus 47 198 64 783 44 758 64 497 25 863 52 118 18 895 12 379 2 440 286 15 061 13 585 14 360 13 257 701 328 Kokku 163 113 165 289 Kokku 163 113 159 126 127 088 32 038 3 987 29 413 28 278 1 135 Tulud Kulud Lplikud eelarveassigneeringud Eelarveaasta lplikku eelarvesse kavandatud tulud Eelmis(t)est eelarveaasta(te)st le kantud assigneeringud NB!
Source: Data supplied by the Agency. 
Allikas: ameti edastatud andmed.
This table summarises the data provided by the Agency in its annual accounts. 
Tabelis vetakse kokku ameti poolt raamatupidamise aastaaruandes esitatud andmed.
Revenue collected and payments are estimated on a cash basis. 
Kogutud tulud ja maksed on arvutatud kassaphiselt.
Table 2 European Medicines Agency (London) Ń Implementation of the budget for the financial year 2007 entered 51 132 committed 49 871 paid 49 107 carried over cancelled 1 261 entered 767 paid 661 cancelled 106 (1 000 euro) 
III jaotis Phitegevus Tabel 2 Euroopa Ravimiamet (London) Đ eelarve titmine 2007. eelarveaastal kajastatud makstud lekantud kajastatud makstud (1 000 eurot)